Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Advanced Gastric Cancer × Oxaliplatin × Clear all

Phase

Status

Completed 5 Unknown 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 73 Colorectal Neoplasms 62 Rectal Neoplasms 41 Colonic Neoplasms 24 Pancreatic Neoplasms 18 Carcinoma, Hepatocellular 17 Neoplasm Metastasis 15 Esophageal Neoplasms 9 Neoplasms 7 Lymphoma, Large B-Cell, Diffuse 7 Liver Neoplasms 7 Cholangiocarcinoma 7 Biliary Tract Neoplasms 6 Colorectal Cancer Metastatic 5 Carcinoma, Non-Small-Cell Lung 5 Recurrence 4 Lymphoma, Extranodal NK-T-Cell 4 Unspecified Adult Solid Tumor, Protocol Specific 3 Gastrointestinal Neoplasms 3 Gallbladder Neoplasms 3 Esophageal Squamous Cell Carcinoma 3 Solid Tumors 2 Neurotoxicity Syndromes 2 Lymphoma 2 Lung Neoplasms 2 Locally Advanced Rectal Cancer 2 Elderly Metastatic Colorectal Cancer Patients 2 Digestive System Neoplasms 2 Carcinoma, Squamous Cell 2 Breast Neoplasms 2

Interventions

Paclitaxel 5 apatinib 4 camrelizumab 3 S 1 (combination) 2 Capecitabine 2 130-nm albumin-bound paclitaxel 2 vorolanib 1 titanium silicide 1 spartalizumab 1 raltitrexed 1 lobaplatin 1 Ramucirumab 1 Oxaliplatin 1 Gastrectomy 1 Docetaxel 1 Control Groups 1 Cisplatin 1 CF regimen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02038621 2014-01-16

GZH-001

The Second People's Hospital of Sichuan

Phase 2 Unknown

Gastrointestinal

Advanced Gastric Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡